JNJ · NYSE · STOCK
Johnson & Johnson (JNJ) Stock Analysis
$273.03
52W $173.33 – $276.47
56/100
$651.25B
31.2
0.23
Is JNJ Bullish or Bearish?
Bullish.
Innellis AI committee rates Johnson & Johnson (JNJ) Buy with a composite score of 56/100
, based on 5 analysts with 60% agreement.
Last updated August 25, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +19.45 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -0.55 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is price structure making higher highs and higher lows. The main limiting factor is eps declining -7.8% yoy despite any revenue growth. The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- ROE of 25.7% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.1% pays you to wait — Value
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 29.9 is moderate-to-rich — Value
- Price-to-book of 6.1x prices in significant intangible value — Value
- EPS declining -7.8% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 25, 2026
Overall Committee Score
56/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 65%
of 192 Healthcare peers
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 25.7% shows genuine earnings power backing the valuation
− P/E of 29.9 is moderate-to-rich
Growth Analyst
bearish
32
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -7.8% YoY despite any revenue growth
Technical Analyst
bullish
69
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 98 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Investment Thesis Evolution
Committee score moved marginally from 55.5 to 55.5.
Comparing 2026-08-24 to 2026-08-25 (1 day apart).
Technical Analysis
RSI (14)
64.3
Neutral
MACD Histogram
0.745
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.86
Inside Bands
Price vs Moving Averages
EMA 9
$266.28
Above
EMA 21
$262.30
Above
EMA 50
$255.12
Above
EMA 200
$231.05
Above
Fundamental Analysis
Valuation
46
Growth
62
Profitability
100
Financial Health
60
Cash Flow
70
Valuation
P/E Ratio
31.2×
P/B Ratio
7.76×
PEG Ratio
-3.87
Dividend Yield
1.94%
52W High
$276.47
52W Low
$173.33
Quality & Growth
ROE
3287.1%
ROA
1345.5%
Gross Margin
7045.2%
Operating Margin
2681.1%
Revenue Growth YoY
—
Debt / Equity
0.58
AI Fundamental Assessment
P/E ratio of 31.2 (rich relative to a 15-40x range); Price-to-book of 7.8x; PEG ratio of -3.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 32.9%; Return on assets of 13.5%; Net margin of 21.5%; Gross margin of 70.5%; Current ratio of 1.09 (tight short-term liquidity); Debt-to-equity of 0.58; Free cash flow per share is positive (7.67); Most recent quarter beat estimates by 0.9%; 2 consecutive earnings beats; EPS growth decelerating (+9.8% -> +7.4% QoQ); Average YoY EPS growth of 4.7%; Analyst estimates rising over recent quarters
Get the Full JNJ Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →